)
Climb Bio (CLYM) investor relations material
Climb Bio Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Annual meeting scheduled for June 5, 2026, to be held exclusively online for shareholders of record as of April 7, 2026.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report on Form 10-K, are available online, with paper copies available upon request.
Voting matters and shareholder proposals
Election of two Class II directors, Alexander (Bo) Cumbo and Douglas Williams, Ph.D., each for a three-year term expiring at the 2029 Annual Meeting.
Ratification of PricewaterhouseCoopers LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.
Approval of an amendment to the Certificate of Incorporation regarding removal of directors for "cause."
Approval of an amendment to the 2021 Equity Incentive Plan to include prefunded warrants in the annual share pool increase calculation.
Provision for transaction of any other business that may properly come before the meeting.
Board of directors and corporate governance
Board recommends voting FOR all director nominees and all proposals on the agenda.
- Key votes include director elections, auditor ratification, and equity plan amendment.CLYM
Proxy filing24 Apr 2026 - Annual meeting to vote on directors, auditor, and key amendments; board recommends approval.CLYM
Proxy filing10 Apr 2026 - Multiple clinical readouts in 2026 will highlight differentiated B-cell therapies and pipeline progress.CLYM
Leerink Global Healthcare Conference 20269 Mar 2026 - Multiple clinical readouts expected in 2026 for novel mAbs targeting immune-mediated diseases.CLYM
Corporate presentation5 Mar 2026 - Clinical pipeline advanced, cash runway into 2028, and key data readouts expected in 2026.CLYM
Q4 20255 Mar 2026 - Multiple clinical readouts expected in 2024 for antibody therapies in PMN, ITP, and IgAN.CLYM
Oppenheimer 36th Annual Healthcare Life Sciences Conference25 Feb 2026 - Five clinical readouts in 2024 and strong cash runway drive autoimmune pipeline progress.CLYM
Guggenheim Securities Emerging Outlook: Biotech Summit 202612 Feb 2026 - Multiple clinical readouts expected in 2026 for novel mAbs targeting immune-mediated diseases.CLYM
Investor Presentation8 Jan 2026 - Advancing monoclonal antibodies for immune diseases, with strong clinical data and robust financial support.CLYM
Leerink Global Healthcare Conference 202526 Dec 2025
Next Climb Bio earnings date
Next Climb Bio earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
Frequently asked questions
Explore our global coverage